Question 1

What specific genetic mutations does my child have, and how do they relate to this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the ELX/TEZ/IVA treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options currently available for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment process look like for my child, including visits and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any risks associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

Question 6

How will we know if the treatment is working for my child?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Evaluation of ELX/TEZ/IVA in Cystic Fibrosis (CF) Subjects 2 Through 5 Years clinical trial (NCT04537793). Contact the study team or your healthcare provider for specific answers.

What this study is about